CD14 and type 2 diabetes mellitus: To assess the impact of TGF-β1 on endothelial resistance to growth factors and monocyte dysfunction, L.M. Makowski and co-authors examined CD14++CD16− monocytes from 41 patients without T2DM and 24 individuals with T2DM.